Sildenafil increases digital skin blood flow during all phases of local cooling in primary Raynaud's Phenomenon

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 5, 2012, Pages 813-819

  Roustit, M ^a,b   Hellmann, M ^a   Cracowski, C ^a   Blaise, S ^a,b   Cracowski, J L ^a,b  

^a University Grenoble Alpes   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PARACETAMOL; SILDENAFIL;

ADULT; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONDUCTANCE; CONTROLLED STUDY; COOLING; CUTANEOUS VASCULAR CONDUCTANCE; DRUG EFFECT; DRUG INDUCED HEADACHE; DRUG POTENTIATION; FEMALE; FINGER; FLUSHING; HUMAN; MALE; NOSE CONGESTION; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SIDE EFFECT; SKIN BLOOD FLOW; SKIN TEMPERATURE;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; RAYNAUD DISEASE; REGIONAL BLOOD FLOW; SKIN; SKIN TEMPERATURE; SULFONES;

EID: 84859948539     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.302     Document Type: Article

References (31)

1. Herrick, A.L. Pathogenesis of Raynaud's phenomenon. Rheumatology (Oxford) 44, 587-96 (2005).
2. Cooke, J.P. & Marshall, J.M. Mechanisms of Raynaud's disease. Vasc. Med. 10, 293-307 (2005).
3. Bunker, C.B., Goldsmith, P.C., Leslie, T.A., Hayes, N., Foreman, J.C. & Dowd, P.M. Calcitonin gene-related peptide, endothelin-1, the cutaneous microvasculature and Raynaud's phenomenon. Br. J. Dermatol. 134, 399-406 (1996).
4. Roustit, M., Simmons, G.H., Baguet, J.P., Carpentier, P. & Cracowski, J.L. Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis. J. Rheumatol. 35, 1576-1583 (2008).
5. Furspan, P.B., Chatterjee, S. & Freedman, R.R. Increased tyrosine phosphorylation mediates the cooling-induced contraction and increased vascular reactivity of Raynaud's disease. Arthritis Rheum. 50, 1578-1585 (2004).
6. Roustit, M., Blaise, S., Millet, C. & Cracowski, J.L. Impaired transient vasodilation and increased vasoconstriction to digital local cooling in primary Raynaud's phenomenon. Am. J. Physiol. Heart Circ. Physiol. 301, H324-H330 (2011).
7. Johnson, J.M. & Kellogg, D.L. Jr. Local thermal control of the human cutaneous circulation. J. Appl. Physiol. 109, 1229-1238 (2010).
8. Levien, T.L. Advances in the treatment of Raynaud's phenomenon. Vasc. Health Risk Manag. 6, 167-177 (2010).
9. De LaVega, A.J. & Derk, C.T. Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication. Expert Opin. Investig. Drugs 18, 23-29 (2009).
10. Roustit, M., Maggi, F., Isnard, S., Hellmann, M., Bakken, B. & Cracowski, J.L. Reproducibility of a local cooling test to assess microvascular function in human skin. Microvasc. Res. 79, 34-39 (2010).
11. Bunker, C.B., Terenghi, G., Springall, D.R., Polak, J.M. & Dowd, P.M. Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon. Lancet 336, 1530-1533 (1990).
12. Hodges, G.J. & Johnson, J.M. Adrenergic control of the human cutaneous circulation. Appl. Physiol. Nutr. Metab. 34, 829-839 (2009).
13. Thompson-Torgerson, C.S., Holowatz, L.A., Flavahan, N.A. & Kenney, W.L. Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin. Am. J. Physiol. Heart Circ. Physiol. 292, H1700-H1705 (2007).
14. Blaise, S., Hellmann, M., Roustit, M., Isnard, S. & Cracowski, J.L. Oral sildenafil increases skin hyperaemia induced by iontophoresis of sodium nitroprusside in healthy volunteers. Br. J. Pharmacol. 160, 1128-1134 (2010).
15. Goldstein, I., Lue, T.F., Padma-Nathan, H., Rosen, R.C., Steers, W.D. & Wicker, P.A. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N. Engl. J. Med. 338, 1397-1404 (1998).
16. Fries, R., Shariat, K., von Wilmowsky, H. & Böhm, M. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Circulation 112, 2980-2985 (2005).
17. Herrick, A.L. et al. Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis. Arthritis Rheum. 63, 775-782 (2011).
18. Friedman, E.A., Harris, P.A., Wood, A.J., Stein, C.M. & Kurnik, D. The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon. Clin. Pharmacol. Ther. 81, 503-509 (2007).
19. Wright, P.J. Comparison of phosphodiesterase type 5 (PDE5) inhibitors. Int. J. Clin. Pract. 60, 967-975 (2006).
20. Caglayan, E. et al. Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease. Arch. Intern. Med. 166, 231-233 (2006).
21. Kumar, N., Griffiths, B. & Allen, J. Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: a potential treatment. J. Rheumatol. 33, 1918-1919 (2006).
22. Minson, C.T., Berry, L.T. & Joyner, M.J. Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J. Appl. Physiol. 91, 1619-1626 (2001).
23. Hodges, G.J., Sharp, L., Clements, R.E., Goldspink, D.F., George, K.P. & Cable, N.T. Influence of age, sex, and aerobic capacity on forearm and skin blood flow and vascular conductance. Eur. J. Appl. Physiol. 109, 1009-1015 (2010).
24. Cankar, K., Finderle, Z. & Strucl, M. Gender differences in cutaneous laser doppler flow response to local direct and contralateral cooling. J. Vasc. Res. 37, 183-188 (2000).
25. Gardner-Medwin, J.M., Macdonald, I.A., Taylor, J.Y., Riley, P.H. & Powell, R.J. Seasonal differences in finger skin temperature and microvascular blood flow in healthy men and women are exaggerated in women with primary Raynaud's phenomenon. Br. J. Clin. Pharmacol. 52, 17-23 (2001).
26. Leppert, J. et al. Seasonal variations in cyclic GMP response on whole-body cooling in women with primary Raynaud's phenomenon. Clin. Sci. 93, 175-179 (1997).
27. LeRoy, E.C. & Medsger, T.A. Jr. Raynaud's phenomenon: a proposal for classification. Clin. Exp. Rheumatol. 10, 485-488 (1992).
28. Merkel, P.A. et al.; Scleroderma Clinical Trials Consortium. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum. 46, 2410-2420 (2002).
29. Cutolo, M., Grassi, W. & Matucci Cerinic, M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum. 48, 3023-3030 (2003).
30. Maricq, H.R. & Weinrich, M.C. Diagnosis of Raynaud's phenomenon assisted by color charts. J. Rheumatol. 15, 454-459 (1988).
31. O'Leary, D.S. Regional vascular resistance vs. conductance: which index for baroreflex responses? Am. J. Physiol. 260, H632-H637 (1991).